Sweetgreen's shares plummeted over 25% after the salad chain revised its 2025 revenue outlook downward for the second consecutive quarter, citing issues with its loyalty program, weak consumer sentiment, tariffs, and store challenges, alongside a disappointing Q2 performance and declining same-store sales.
Novo Nordisk's stock fell 3.8% after the company cut its full-year outlook, citing concerns over its obesity drug franchise led by semaglutide, causing investor worries and a continued decline in share price.
Moody's has advised its staff to work from home ahead of a potential cut to China's outlook, as concerns grow over the impact of the coronavirus outbreak on the country's economy.
Levi Strauss & Co. shares fell over 7% after the company cut its forecast for the year due to inventory issues and lower revenue expectations. The company now expects revenue to grow by 1.5% to 2.5% year over year, compared to the previous forecast of 1.5% to 3% growth, with adjusted earnings of $1.10 to $1.20 a share, down from the previous forecast of $1.30 to $1.40 a share. The inventory backlog and supply-chain challenges have impacted the company's ability to fulfill demand, while higher inflation and a slowing economy have also affected its wholesale business.